Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 6”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableWithdrawnNCT04100889
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+20 more
ProgenaBiome
Early research (Phase 1)Study completedNCT00975481
What this trial is testing

Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 36
Post-approval studies (Phase 4)Study completedNCT00234637
What this trial is testing

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Who this might be right for
Alzheimer's Disease
Novartis 204
Testing effectiveness (Phase 2)Study completedNCT02249403
What this trial is testing

Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 362
Not applicableStudy completedNCT04466735
What this trial is testing

BRain Energy Activation With Ketones to Prevent Alzheimer's Disease

Who this might be right for
MCI
Université de Sherbrooke 65
Testing effectiveness (Phase 2)UnknownNCT05607615
What this trial is testing

A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Cyclo Therapeutics, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT01354691
What this trial is testing

Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementiaMemory Loss+1 more
Avraham Pharmaceuticals Ltd 200
Not applicableLooking for participantsNCT06810960
What this trial is testing

A Postmarketing Study of Lecanemab in South Korean Participants With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Korea Inc. 3,000
Testing effectiveness (Phase 2)Study completedNCT01522404
What this trial is testing

Effects of Atomoxetine in Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
Emory University 39
Large-scale testing (Phase 3)Ended earlyNCT05169008
What this trial is testing

Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents

Who this might be right for
COVID-19
CanSino Biologics Inc. 91
Not applicableStudy completedNCT01312363
What this trial is testing

Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients

Who this might be right for
Alzheimer's Disease
Seoul National University Hospital 300
Testing effectiveness (Phase 2)Study completedNCT03069014
What this trial is testing

Study of LM11A-31-BHS in Mild-moderate AD Patients

Who this might be right for
Mild to Moderate Alzheimer's Disease
PharmatrophiX Inc. 242
Not applicableStudy completedNCT01772095
What this trial is testing

ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE

Who this might be right for
Alzheimer DiseaseDementiaCognitive Disorders
Elpen Pharmaceutical Co. Inc. 389
Not applicableStudy completedNCT04916886
What this trial is testing

A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups.

Who this might be right for
COVID-19
CanSino Biologics Inc. 2,021
Not applicableUnknownNCT02991235
What this trial is testing

Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Bioiberica 30
Post-approval studies (Phase 4)WithdrawnNCT00375557
What this trial is testing

Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients

Who this might be right for
Alzheimer's DiseaseDementiaBehavioral Symptoms
University of Cincinnati
Not applicableStudy completedNCT02978768
What this trial is testing

Tai Chi 6-Form Sports Apparatus With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Chang Gung Memorial Hospital 67
Testing effectiveness (Phase 2)Study completedNCT04566770
What this trial is testing

A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

Who this might be right for
COVID-19
CanSino Biologics Inc. 480
Large-scale testing (Phase 3)Ended earlyNCT01883648
What this trial is testing

Study to Evaluate Coconut Oil for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
University of South Florida 21
Large-scale testing (Phase 3)Ended earlyNCT00954590
What this trial is testing

A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Moderate to Severe Alzheimer
Medivation, Inc. 89
Load More Results